NM_000334.4:c.612-94G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000334.4(SCN4A):c.612-94G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 747,310 control chromosomes in the GnomAD database, including 49,332 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.31   (  8267   hom.,  cov: 30) 
 Exomes 𝑓:  0.36   (  41065   hom.  ) 
Consequence
 SCN4A
NM_000334.4 intron
NM_000334.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.38  
Publications
18 publications found 
Genes affected
 SCN4A  (HGNC:10591):  (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008] 
SCN4A Gene-Disease associations (from GenCC):
- hyperkalemic periodic paralysisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- paramyotonia congenita of Von EulenburgInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- SCN4A-related myopathy, autosomal recessiveInheritance: AR Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- hypokalemic periodic paralysis, type 2Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- potassium-aggravated myotoniaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 16Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital myopathyInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- congenital myopathy 22A, classicInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- acetazolamide-responsive myotoniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypokalemic periodic paralysisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myotonia fluctuansInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myotonia permanensInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BP6
Variant 17-63971347-C-T is Benign according to our data. Variant chr17-63971347-C-T is described in ClinVar as Benign. ClinVar VariationId is 1265211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.401  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.310  AC: 47003AN: 151626Hom.:  8259  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
47003
AN: 
151626
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.362  AC: 215373AN: 595564Hom.:  41065   AF XY:  0.360  AC XY: 113868AN XY: 316676 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
215373
AN: 
595564
Hom.: 
 AF XY: 
AC XY: 
113868
AN XY: 
316676
show subpopulations 
African (AFR) 
 AF: 
AC: 
2418
AN: 
16580
American (AMR) 
 AF: 
AC: 
8114
AN: 
33976
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
7582
AN: 
19252
East Asian (EAS) 
 AF: 
AC: 
10478
AN: 
31848
South Asian (SAS) 
 AF: 
AC: 
17271
AN: 
61508
European-Finnish (FIN) 
 AF: 
AC: 
13017
AN: 
35666
Middle Eastern (MID) 
 AF: 
AC: 
890
AN: 
2492
European-Non Finnish (NFE) 
 AF: 
AC: 
144397
AN: 
362852
Other (OTH) 
 AF: 
AC: 
11206
AN: 
31390
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 6280 
 12560 
 18841 
 25121 
 31401 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1478 
 2956 
 4434 
 5912 
 7390 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.310  AC: 47015AN: 151746Hom.:  8267  Cov.: 30 AF XY:  0.305  AC XY: 22643AN XY: 74122 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
47015
AN: 
151746
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
22643
AN XY: 
74122
show subpopulations 
African (AFR) 
 AF: 
AC: 
6175
AN: 
41456
American (AMR) 
 AF: 
AC: 
4125
AN: 
15264
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1397
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
1586
AN: 
5136
South Asian (SAS) 
 AF: 
AC: 
1270
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
3821
AN: 
10532
Middle Eastern (MID) 
 AF: 
AC: 
108
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
27470
AN: 
67778
Other (OTH) 
 AF: 
AC: 
677
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 1458 
 2916 
 4373 
 5831 
 7289 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 472 
 944 
 1416 
 1888 
 2360 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
943
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.